Krystal Biotech
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $70,284 | $45,250 | $42,143 | $8,556 |
Gross Profit | 62,289 | 42,831 | 37,765 | 8,333 |
EBITDA | 23,052 | 19,925 | 4,645 | -25,993 |
EBIT | 21,066 | 18,316 | 3,138 | -27,193 |
Net Income | 15,568 | 932 | 8,692 | 80,747 |
Net Change In Cash | 70,284 | 45,250 | 42,143 | 8,556 |
Free Cash Flow | -5,299 | 14,628 | -9,079 | -23,007 |
Cash | 345,786 | 359,006 | 358,328 | 373,241 |
Basic Shares | 29,637 | 29,291 | 28,817 | 28,892 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $50,699 | $0 | $0 | $0 |
Gross Profit | 42,598 | -4,054 | -2,769 | -1,851 |
EBITDA | -92,220 | -110,920 | -65,309 | -31,148 |
EBIT | -97,227 | -114,974 | -68,078 | -32,999 |
Net Income | 10,932 | -139,975 | -69,570 | -32,167 |
Net Change In Cash | 50,699 | 0 | 0 | 0 |
Cost of Revenue | 72,977 | 80,755 | ||
Free Cash Flow | -100,603 | -153,548 | -116,274 | -40,926 |
Cash | 358,328 | 161,900 | 341,246 | 268,269 |
Basic Shares | 27,751 | 25,491 | 22,196 | 18,787 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.53 |
2024-03-31 | $0.03 |
2023-12-31 | $0.30 |
2023-09-30 | -$0.69 |
